For the final episode of 2020, we look back at the past year in the pharmaceutical industry, reflecting on the COVID-19 milestones, the major appointments and acquisitions that have taken place, as well as pharma’s transition into digital and the substantial progress made in combatting Ebola, HIV, and Polio.